Pernix Therapeutics Holdings Inc (PTXTQ1)

Sector:
REAL ESTATE
Industry:
REAL ESTATE INVESTMENT TRUSTS
SIC:
REAL ESTATE INVESTMENT TRUSTS
CEO:
John A. Sedor
Employees:
185
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NJ 07960
(862) 260-8457

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.

Data derived from most recent annual or quarterly report
Market Cap 420.79 Thousand Shares Outstanding14.51 Million Avg 30-day Volume 25.828 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.89
Price to Revenue0.1002 Debt to Equity-0.7537 EBITDA-3.828 Million
Price to Book Value0.0 Operating Margin-38.1273 Enterprise Value150.657 Million
Current Ratio1.082 EPS Growth0.576 Quick Ratio0.815
1 Yr BETA 0.0982 52-week High/Low 0.0 / Profit Margin-67.125
Operating Cash Flow Growth-681.7603 Altman Z-Score-2.4863 Free Cash Flow to Firm -23.277 Million
View SEC Filings from PTXTQ1 instead.

View recent insider trading info

Funds Holding PTXTQ1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PTXTQ1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-06-26:
    Item 1.03: Bankruptcy or Receivership
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K: filed on 2019-05-14:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2019-04-19:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-02-19:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.03: Bankruptcy or Receivership
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-21:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2018-11-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2018-10-22:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K/A: filed on 2018-10-09:
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PINA KENNETH SVP, GC,COMPLIANCE OFF & SEC

    • Officer
    14,726 2019-01-05 0

    SEDOR JOHN A CHAIRMAN OF BOARD AND CEO

    • Officer
    • Director
    133,140 2018-08-08 0

    WHALEY GLENN VP OF FIN, PAO & CONTROLLER

    • Officer
    3,616 2018-08-08 0

    SMITH ANGUS W. SVP, CBO & PRINCIPAL FIN OFF

    • Officer
    8,018 2018-08-08 0

    LEUNG GABRIEL

    • Director
    0 2018-05-22 0

    LANGER DENNIS

    • Director
    0 2018-05-22 0

    LEONE JOHN R

    • Director
    0 2018-05-22 0

    SWIRSKY DOUGLAS J

    • Director
    0 2018-05-22 0

    MIAO GRAHAM G PRESIDENT AND CFO

    • Officer
    • Director
    64,035 2017-08-08 0

    GOLEMBIEWSKI MICHAEL JOSEPH VP FINANCE, CONTROLLER, CAO

    • Officer
    3,300 2017-08-08 0

    ELMS STEVE

    • Director
    2,000,000 2016-05-26 0

    KONIDARIS TASOS

    • Director
    0 2016-05-26 0

    NOVAK TERENCE CHIEF OPERATING OFFICER

    • Officer
    0 2016-02-25 0

    DRYSDALE DOUGLAS CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2016-02-25 0

    SHALABY RICK SVP COMMERCIAL OPERATIONS

    • Officer
    0 2016-02-25 0

    PATEL SANJAY S CHIEF FINANCIAL OFFICER

    • Officer
    0 2016-02-25 0

    SIEGEL BARRY J SENIOR VP AND GENERAL COUNSEL

    • Officer
    0 2016-02-25 0

    CLIFFORD TRACY SIMMONS PRINCIPAL ACCOUNTING OFFICER

    • Officer
    7,506 2014-11-03 0

    DORSEY BRIAN SVP RESEARCH

    • Officer
    87,426 2014-10-10 0

    SMITH JAMES EDWARD JR.

    • 10% Owner
    3,501,704 2014-05-19 0

    COLLINS COOPER C. CHIEF STRATEGIC OFFICER

    • Officer
    3,526,571 2014-04-01 0

    PEARCE MICHAEL COOPER PRESIDENT AND CEO

    • Officer
    • Director
    286,667 2013-05-10 0

    BECKER DAVID PAUL CHIEF FINANCIAL OFFICER

    • Officer
    200,000 2012-12-07 0

    BLANCHARD ANTHEM H.

    • Director
    45,000 2012-03-22 0

    HRUSHKA CHARLES S VP OF SALES AND MARKETING

    • Officer
    0 2012-01-20 0

    LOEB JAN H

    • Director
    448,550 2011-03-11 0

    VENTERS MICHAEL EXECUTIVE VP OF OPERATIONS

    • Officer
    0 2010-05-12 0

    GOTTLIEB JAY

    • Director
    0 2010-01-03 0

    COUCHMAN JONATHAN

    • Director
    0 2010-01-03 0

    VLAHOS WILLIAM

    • Director
    • 10% Owner
    474,800 2008-05-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments